Page last updated: 2024-11-05

biphenyl-3-carboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

biphenyl-3-carboxylic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12854
CHEMBL ID123234
SCHEMBL ID250880
MeSH IDM0267377

Synonyms (43)

Synonym
4-09-00-02478 (beilstein handbook reference)
F2191-0023
716-76-7
nsc178898
nsc-178898
diphenyl-3-carboxylic acid
3-biphenylcarboxylic acid
[1,1'-biphenyl]-3-carboxylic acid
wln: qvr cr
3-phenylbenzoic acid
AE-641/02442054
brn 1868625
(1,1'-biphenyl)-3-carboxylic acid
nsc 178898
biphenyl-3-carboxylic acid
nsc 408030
nsc-408030
nsc408030
CHEMBL123234 ,
AKOS002678497
A9373
1,1'-biphenyl-3-carboxylic acid
B3850
FT-0630079
AM20050319
SCHEMBL250880
SY012973
mfcd00045846
DTXSID40221833
3-biphenyl carboxylic acid
3-phenyl benzoic acid
meta-phenyl benzoic acid
STR08811
PS-8241
AC-24617
1,1'-biphenyl, 3-carboxy acid
J-511773
biphenyl-3-carboxylic acid, 97%
CS-W002224
bdbm50195793
EN300-265725
1-carboxy-3-phenylbenzene
W48UX3L48Z
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)21.64500.03403.987110.0000AID1628074; AID1628075
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Beta-lactamase Klebsiella pneumoniaeKd370.00000.85000.85000.8500AID1320842
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (5)

Processvia Protein(s)Taxonomy
cellular response to starvationAlbuminHomo sapiens (human)
negative regulation of mitochondrial depolarizationAlbuminHomo sapiens (human)
cellular response to calcium ion starvationAlbuminHomo sapiens (human)
cellular oxidant detoxificationAlbuminHomo sapiens (human)
transportAlbuminHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (12)

Processvia Protein(s)Taxonomy
oxygen bindingAlbuminHomo sapiens (human)
DNA bindingAlbuminHomo sapiens (human)
fatty acid bindingAlbuminHomo sapiens (human)
copper ion bindingAlbuminHomo sapiens (human)
protein bindingAlbuminHomo sapiens (human)
toxic substance bindingAlbuminHomo sapiens (human)
antioxidant activityAlbuminHomo sapiens (human)
pyridoxal phosphate bindingAlbuminHomo sapiens (human)
identical protein bindingAlbuminHomo sapiens (human)
protein-folding chaperone bindingAlbuminHomo sapiens (human)
exogenous protein bindingAlbuminHomo sapiens (human)
enterobactin bindingAlbuminHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
extracellular regionAlbuminHomo sapiens (human)
extracellular spaceAlbuminHomo sapiens (human)
nucleusAlbuminHomo sapiens (human)
endoplasmic reticulumAlbuminHomo sapiens (human)
endoplasmic reticulum lumenAlbuminHomo sapiens (human)
Golgi apparatusAlbuminHomo sapiens (human)
platelet alpha granule lumenAlbuminHomo sapiens (human)
extracellular exosomeAlbuminHomo sapiens (human)
blood microparticleAlbuminHomo sapiens (human)
protein-containing complexAlbuminHomo sapiens (human)
cytoplasmAlbuminHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID1628076Potency index, ratio of IC50 for benzoic acid to IC50 for test compound for inhibition of mushroom tyrosinase monophenolase activity2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors.
AID1628074Inhibition of mushroom tyrosinase monophenolase activity using L-tyrosine as substrate measured every 60 s for 25 times2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors.
AID1628075Inhibition of mushroom tyrosinase diphenolase activity using L-DOPA as substrate measured every 30 s for 25 times2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors.
AID89369Transthyretin (TTR) amyloidogenesis inhibition activity by employing an acid-mediated (pH 4.4) WTTTR amyloid fibril formation assay, at 7.2 uM conc.2004Journal of medicinal chemistry, Jan-15, Volume: 47, Issue:2
Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.
AID1486519Binding affinity to transthyretin in human blood plasma assessed as plasma binding selectivity by measuring stoichiometry of small molecule bound to TTR incubated for 24 hrs at 37 degC by RP-HPLC2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
AID243230Binding affinity towards human serum albumin2005Journal of medicinal chemistry, Apr-07, Volume: 48, Issue:7
Predicting human serum albumin affinity of interleukin-8 (CXCL8) inhibitors by 3D-QSPR approach.
AID1486518Inhibition of acid-induced wild type transthyretin (unknown origin) aggregation expressed in Escherichia coli pre-incubated for 30 mins before acid addition and further incubated for 72 hrs at 37 degC under dark conditions by UV-Vis spectrophotometry2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
AID1467145Inhibition of mushroom tyrosinase using L-tyrosinase as substrate measured at 60 secs interval for 25 times2017Bioorganic & medicinal chemistry letters, 07-01, Volume: 27, Issue:13
Structural insight into the active site of mushroom tyrosinase using phenylbenzoic acid derivatives.
AID1320842Binding affinity to native signal deficient and TEV cleavage site containing His-tagged Klebsiella pneumoniae OXA-48 expressed in Escherichia coli assessed as dissociation constant by SPR assay2016Journal of medicinal chemistry, 06-09, Volume: 59, Issue:11
Screening and Design of Inhibitor Scaffolds for the Antibiotic Resistance Oxacillinase-48 (OXA-48) through Surface Plasmon Resonance Screening.
AID1628073Ratio of IC50 for mushroom tyrosinase diphenolase activity using L-DOPA as substrate to IC50 for mushroom tyrosinase monophenolase activity using L-tyrosine as substrate2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors.
AID1320843Inhibition of native signal containing Klebsiella pneumoniae OXA-48 using nitrocefin substrate pre-incubated for 5 mins before substrate addition2016Journal of medicinal chemistry, 06-09, Volume: 59, Issue:11
Screening and Design of Inhibitor Scaffolds for the Antibiotic Resistance Oxacillinase-48 (OXA-48) through Surface Plasmon Resonance Screening.
AID1628078Mixed-type inhibition of mushroom tyrosinase diphenolase activity using L-DOPA as substrate at 3 to 30 uM measured every 30 s for 25 times by Lineweaver-Burk plot analysis2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors.
AID1628077Non-competitive inhibition of mushroom tyrosinase monophenolase activity using L-tyrosine as substrate at 5 to 10 uM measured every 60 s for 25 times by Lineweaver-Burk plot analysis2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.15 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index17.79 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]